Abstract
Subcutaneous patient-controlled analgesia (SCPCA) in home-based palliative care is a potentially valuable option for providing effective pain relief to some patients, particularly when conventional analgesic approaches prove ineffective or are refused. Our case report illustrates the use of SPCA for the management of breakthrough pain in a patient receiving palliative care at home with no improvement after multiple previous treatments. SCPCA was found to be safe and successful. Future research is essential to explore its precise role, appropriate indications, prescription guidelines, and safety considerations across various palliative care contexts.
Ethical approval
This study constituted an intervention conducted within the scope of standard medical practice, therefore submission to Institutional Review Board was not required.
Authors contributions
MJ and PC contributed to the data collection. MJ and EB were responsible for the initial draft of the manuscript, which was subsequently reviewed and commented on by all authors. The final manuscript received unanimous approval from all authors.
Disclosure statement
No potential conflict of interest was reported by the author(s).